Skip to content
Home/Companies/Healthcare/ManRos Therapeutics

ManRos Therapeutics

Healthcare·Roscoff, Brittany, France·Active·15yr hold
Entry
2011
Hold
15yr
Status
Active

Who owns ManRos Therapeutics?

ManRos Therapeutics is currently owned by Angels Capital through Angels Capital (2008 vintage), since 2011.

Hand-verified · updated 2026-04-21

Angels Capital
Most recent investor
Angels Capital
Angels Capital · 2008 · VC
3 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

3 ownership periods

Active
Currently held by Angels Capital since 2011.
Angels Capital
Angels CapitalActive
2011 · present(15yr) · Angels Capital · 2008 · VC
Angels Capital
Angels CapitalActive
2011 · present(15yr) · Angels Capital · 2008 · VC
Angels Capital
Angels CapitalActive
2011 · present(15yr) · Angels Capital · 2008 · VC

More from Angels Capital

Other portfolio companies in the same fund.

Citring
Citring
Active
ConsumerSpain· 2026
CoCircular
Active
ClimateTechSpain· 2026
IONLY
Ionly
Active
EnergySpain· 2026
Ola Creators
Active
HR TechSpain· 2026
TRAK
TRAK
Active
HealthTechSpain· 2026
Biotasmart
Active
HealthTechSpain· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Manros Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Manros Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue